{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T17:16:32Z","timestamp":1778001392514,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.medcli.2026.107411","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T17:19:59Z","timestamp":1773854399000},"page":"107411","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic value of interim PET-CT in follicular lymphoma"],"prefix":"10.1016","volume":"166","author":[{"given":"Sunil","family":"Lakhwani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"D\u00edaz-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dolores","family":"Cabello-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"De Bonis-Braun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Jos\u00e9 Rodr\u00edguez-Salazar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bel\u00e9n","family":"P\u00e9rez-Pinilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Mart\u00edn-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel T.","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2026.107411_bib0145","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s00277-020-03918-6","article-title":"RELINF: prospective epidemiological registry of lymphoid neoplasms in Spain. A project from the GELTAMO group","volume":"99","author":"Bastos-Oreiro","year":"2020","journal-title":"Ann Hematol"},{"key":"10.1016\/j.medcli.2026.107411_bib0150","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1200\/JCO.2014.59.7534","article-title":"Early relapse of follicular lymphoma after rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone defines patients at high risk for death: an analysis from the National LymphoCare Study","volume":"33","author":"Casulo","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.medcli.2026.107411_bib0155","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.medcli.2021.03.041","article-title":"Follicular lymphoma: an update on diagnosis, prognosis, and management","volume":"157","author":"Mozas","year":"2021","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.medcli.2026.107411_bib0160","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1182\/blood-2003-12-4434","article-title":"Follicular lymphoma international prognostic index","volume":"104","author":"Solal-C\u00e9ligny","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2026.107411_bib0165","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1200\/JCO.2008.21.3991","article-title":"Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the International Follicular Lymphoma Prognostic Factor Project","volume":"27","author":"Federico","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.medcli.2026.107411_bib0170","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1182\/blood-2017-11-816405","article-title":"A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy","volume":"132","author":"Bachy","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2026.107411_bib0175","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S1470-2045(15)00169-2","article-title":"Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry","volume":"16","author":"Pastore","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.medcli.2026.107411_bib0180","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41408-021-00521-4","article-title":"Lack of intrafollicular memory CD4+ T cells is predictive of early clinical failure in newly diagnosed follicular lymphoma","volume":"11","author":"Mondello","year":"2021","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.medcli.2026.107411_bib0185","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1200\/JCO.2013.53.5229","article-title":"Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group","volume":"32","author":"Barrington","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.medcli.2026.107411_bib0190","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.medcli.2026.107411_bib0195","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/S1470-2045(18)30618-1","article-title":"Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial","volume":"19","author":"Trotman","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.medcli.2026.107411_bib0200","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1053\/j.semnuclmed.2022.10.004","article-title":"Interim FDG-PET\/CT for response assessment of lymphoma","volume":"53","author":"Zeman","year":"2023","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.medcli.2026.107411_bib0205","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1080\/10428190701422059","article-title":"Predictive value and diagnostic accuracy of F-18-fluoro-deoxy-glucose positron emission tomography treated grade 1 and 2 follicular lymphoma","volume":"48","author":"Bishu","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.medcli.2026.107411_bib0210","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1200\/JCO.2012.43.0934","article-title":"Impact of [(18)F]fluorodeoxyglucose positron emission tomography response evaluation in patients with high-tumor burden follicular lymphoma treated with immunochemotherapy: a prospective study from the Groupe d\u2019\u00c9tudes des Lymphomes de l\u2019Adulte and GOELAMS","volume":"30","author":"Dupuis","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.medcli.2026.107411_bib0215","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s12149-014-0874-1","article-title":"The prognostic value of mid- and post-treatment [(18)F]fluorodeoxyglucose (FDG) positron emission tomography (PET) in indolent follicular lymphoma","volume":"28","author":"Lu","year":"2014","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.medcli.2026.107411_bib0220","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s13139-019-00602-0","article-title":"Predictive value of interim and end-of-therapy 18F-FDG PET\/CT in patients with follicular lymphoma","volume":"53","author":"Boo","year":"2019","journal-title":"Nucl Med Mol Imaging"},{"key":"10.1016\/j.medcli.2026.107411_bib0225","doi-asserted-by":"crossref","first-page":"6871","DOI":"10.2147\/CMAR.S216445","article-title":"Prognostic values of baseline, interim and end-of therapy 18F-FDG PET\/CT in patients with follicular lymphoma","volume":"11","author":"Zhou","year":"2019","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.medcli.2026.107411_bib0230","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00277-023-05138-0","article-title":"Prognostic value of interim 18F-FDG PET\/CT in adult follicular lymphoma treated with R-CHOP","volume":"102","author":"Sun","year":"2023","journal-title":"Ann Hematol"},{"key":"10.1016\/j.medcli.2026.107411_bib0235","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000826","article-title":"Interim positron emission tomography during frontline chemoimmunotherapy for follicular lymphoma","volume":"7","author":"Merryman","year":"2023","journal-title":"Hemasphere"},{"key":"10.1016\/j.medcli.2026.107411_bib0240","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3390\/cancers17071065","article-title":"Exploratory study to evaluate the impact of interim PET\/CT assessment in first-line follicular lymphoma","volume":"17","author":"Poza","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.medcli.2026.107411_bib0245","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1182\/bloodadvances.2024014790","article-title":"Prognostic role of interim PET in follicular lymphoma: a post hoc study of FOLL12 trial by Fondazione Italiana Linfomi","volume":"9","author":"Durmo","year":"2025","journal-title":"Blood Adv"},{"key":"10.1016\/j.medcli.2026.107411_bib0250","doi-asserted-by":"crossref","first-page":"6485","DOI":"10.1182\/blood-2022-158271","article-title":"Prognostic significance of interim PET\/CT in follicular lymphoma treated with frontline chemoimmunotherapy","volume":"140","author":"Laverdure","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2026.107411_bib0255","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3390\/cancers17010073","article-title":"Prognostic significance of interim PET\/CT in the first-line treatment of follicular lymphoma patients, a single-center experience","volume":"17","author":"Kiss","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.medcli.2026.107411_bib0260","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.4143\/crt.2018.649","article-title":"Prognostic value of baseline and interim total metabolic tumor volume and total lesion glycolysis measured on 18F-FDG PET-CT in patients with follicular lymphoma","volume":"51","author":"Liang","year":"2019","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.medcli.2026.107411_bib0265","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00277-015-2553-2","article-title":"Prognostic value of interim and end-of-treatment FDG-PET in follicular lymphoma: a systematic review","volume":"95","author":"Adams","year":"2016","journal-title":"Ann Hematol"},{"key":"10.1016\/j.medcli.2026.107411_bib0270","article-title":"Deauville score-based evaluation of interim PET\/CT in follicular lymphoma: a prognostic factor systematic review and meta-analysis","volume":"16","author":"Fonseca","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.medcli.2026.107411_bib0275","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1470-2045(21)00591-X","article-title":"Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial","volume":"23","author":"Jacobson","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.medcli.2026.107411_bib0280","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S1470-2045(22)00335-7","article-title":"Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study","volume":"23","author":"Budde","year":"2022","journal-title":"Lancet Oncol"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775326000618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775326000618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T16:42:06Z","timestamp":1777999326000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775326000618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0025775326000618"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2026.107411","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic value of interim PET-CT in follicular lymphoma","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2026.107411","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"107411"}}